Further corroborating the involvement of ligand-induced ERα activation in this response, the recruitment of Sp1 and ERα to the PARP-1 promoter region was prevented using fulvestrant in the aforementioned BC cells (Fig. 2G-I). The gene discussed is ESR1; the disease is breast cancer.